Cromolyn effects on vernal keratoconjunctivitis in children
K. F. Tabbara and N. T. Arafat
A double-masked, coded trial was undertaken to evaluate the effect of the
topical administration of 2% cromolyn sodium eye drops on vernal
keratoconjunctivitis in 14 children. One eye of each patient was treated
for one year with cromoly, the other eye with placebo. Cromolyn reduced the
characteristic vernal keratitis, vernal corneal ulcers and plaques, and
limbal edema and infiltrates but did not affect the number or size of the
giant papillae. The drug's long-term topical use did not have any adverse
side effects.
